ERS leaders' top picks


As ERS President, what are you most looking forward to about this year’s congress?

The ERS annual conference is the largest annual respiratory event in the world. After two virtual conferences in 2020 and 2021, the ERS is delighted to warmly welcome all respiratory stakeholders in beautiful Barcelona to meet and share updates on all aspects of pulmonary medicine. Since 2020 and the COVID-19 outbreak, the ERS has developed an outstanding ability to organize high-quality digital conferences, allowing close intereactions and discussion. I have very high expectations that this hybrid 2022 ERS congress will offer a vibrant face-to-face scientific conference and the best digital scientific offering to the respiratory community in Barcelona and worldwide.

What in your opinion will be the hot topics for pulmonary vascular disease specialists?

The ERS Assembly 13 is a major player in the field of rare and common pulmonary vascular diseases such as pulmonary hypertension and pulmonary embolism. Pulmonary embolism and pulmonary hypertension are major cardiopulmonary diseases which have been the focus of intense research and excellent quality practice guidelines disseminated in close partnership with our colleagues from the European Society of Cardiology (ESC). This year the joint ESC/ERS Guidelines on pulmonary hypertension will be published in the European Respiratory Journal and several discussions on the implementation and refinement of these guidelines will be of great interest. Moreover, impactful information will be provided on novel approaches for the management of pulmonary vascular diseases.

Tell us your top three picks from the congress programme.

1. The ERS has a privileged relationship with all sister societies. The respiratory medicine meets other disciplines session (16:00–17:30 CEST on 5 September) will discuss the ESC/ERS guidelines on the diagnosis and treatment of pulmonary hypertension with specialists from the ERS and the ESC. This session will clarify several key questions of major importance in our clinical practice. The novelties presented in this session will move the field forward.

2. During the state of the art session entitled “Pulmonary vascular diseases” (14:15–15:45 CEST on 5 September), important information will be shared on pulmonary hypertension complicating the course of lung disease and auto-immune disease.

3. The symposium on “clinical challenges beyond guidelines” (11:15–12:45 on 6 September) will discuss the imaging of pulmonary embolism in pregnancy and the optimal follow-up after an episode of acute pulmonary embolism. These topics require expert guidance and the ERS congress is a unique setting offering strong and clear multidisciplinary expertise.

Check out all top picks by the ERS leadership

View all ERS Congress programme highlights